Michael A.  Smith net worth and biography

Michael Smith Biography and Net Worth

EVP of PetIQ
Mr. Smith joined PetIQ in May of 2019 as our Executive Vice President for the Product Division. Prior to joining PetIQ, he spent nine years in various leadership roles across the Consumables Merchandising Division at Walmart Inc., culminating with a four year tenure as Senior Director in the Pet Department. Prior to joining Walmart, Mr. Smith spent 10 years in the consumer goods industry with Procter & Gamble and Gillette, where he held a variety of roles across sales, finance and logistics. Mr. Smith earned a Bachelor’s degree in Finance and Supply Chain Management from the University of Arkansas.

What is Michael A. Smith's net worth?

The estimated net worth of Michael A. Smith is at least $400,167.48 as of May 20th, 2022. Mr. Smith owns 21,891 shares of PetIQ stock worth more than $400,167 as of March 28th. This net worth evaluation does not reflect any other assets that Mr. Smith may own. Additionally, Mr. Smith receives an annual salary of $1,340,000.00 as EVP at PetIQ. Learn More about Michael A. Smith's net worth.

How old is Michael A. Smith?

Mr. Smith is currently 46 years old. There are 2 older executives and no younger executives at PetIQ. The oldest executive at PetIQ is Mr. Zvi Glasman, Chief Financial Officer, who is 60 years old. Learn More on Michael A. Smith's age.

What is Michael A. Smith's salary?

As the EVP of PetIQ, Inc., Mr. Smith earns $1,340,000.00 per year. The highest earning executive at PetIQ is Mr. McCord Christensen, Chairman of the Board & CEO, who commands a salary of $2,000,000.00 per year. Learn More on Michael A. Smith's salary.

How do I contact Michael A. Smith?

The corporate mailing address for Mr. Smith and other PetIQ executives is 923 S. Bridgeway Pl., EAGLE ID, 83616. PetIQ can also be reached via phone at (208) 939-8900 and via email at [email protected]. Learn More on Michael A. Smith's contact information.

Has Michael A. Smith been buying or selling shares of PetIQ?

Michael A. Smith has not been actively trading shares of PetIQ over the course of the past ninety days. Most recently, on Monday, May 23rd, Michael A. Smith bought 3,600 shares of PetIQ stock. The stock was acquired at an average cost of $14.06 per share, with a total value of $50,616.00. Following the completion of the transaction, the executive vice president now directly owns 25,491 shares of the company's stock, valued at $358,403.46. Learn More on Michael A. Smith's trading history.

Who are PetIQ's active insiders?

PetIQ's insider roster includes McCord Christensen (CEO), Robert Herrman (General Counsel), Ronald Kennedy (Director), John Newland (CFO), Susan Sholtis (President), and Michael Smith (EVP). Learn More on PetIQ's active insiders.

Michael A. Smith Insider Trading History at PetIQ

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/23/2022Buy3,600$14.06$50,616.0025,491View SEC Filing Icon  
5/20/2022Buy1,400$14.06$19,684.0021,891View SEC Filing Icon  
12/14/2021Buy10,000$21.40$214,000.00View SEC Filing Icon  
11/11/2021Buy4,000$22.62$90,480.00View SEC Filing Icon  
6/11/2021Sell13,470$39.53$532,469.10View SEC Filing Icon  
5/19/2021Sell16,947$40.11$679,744.1713,787View SEC Filing Icon  
5/14/2021Sell1,085$40.00$43,400.0013,787View SEC Filing Icon  
3/15/2021Sell11,213$37.75$423,290.751,580View SEC Filing Icon  
See Full Table

Michael A. Smith Buying and Selling Activity at PetIQ

This chart shows Michael A Smith's buying and selling at PetIQ by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

PetIQ Company Overview

PetIQ logo
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho.
Read More

Today's Range

Now: $18.28
Low: $17.51
High: $18.39

50 Day Range

MA: $17.62
Low: $15.55
High: $19.04

2 Week Range

Now: $18.28
Low: $10.78
High: $22.98

Volume

350,928 shs

Average Volume

298,184 shs

Market Capitalization

$537.98 million

P/E Ratio

304.72

Dividend Yield

N/A

Beta

1.65